אימנד 150 מ"ג IV

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Dostupno od:

MERCK SHARP & DOHME ISRAEL LTD

ATC koda:

A04AD12

Farmaceutski oblik:

POWDER FOR SOLUTION FOR INFUSION

Administracija rute:

I.V

Proizveden od:

MERCK SHARP & DOHME B.V, HOLLAND

Terapijska grupa:

APREPITANT

Terapijske indikacije:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Datum autorizacije:

2011-11-01